THE FIRST 10 MINUTES IN NOVEL DRUG DEVELOPMENT ARE CRUCIAL

Tissue is the Issue

We are a biotech company focused on precision oncology. We have created special procedures to collect tissue samples, in particular to keep cold ischemia times to under 10 minutes. This ensures specimens have a very high sample integrity and preserves the expression of therapeutic targets otherwise lost.

Our method results in substantial benefits for the understanding of tumor biology, the discovery of novel targets and the development of precision cancer therapeutics.

Meet us at the 2024 ASCO Annual Meeting to learn more.
June 1 - 4, 2024 | McCormick Place | Chicago, IL, USA | Booth 32137

Join our Poster Presentation

Poster:
Identification of a patient tissue-based phosphorylation site as a biomarker for epidermal growth factor receptor (EGFR) activity in non-small cell lung cancer

Session Category: Developmental Therapeutics / Molecularly Targeted Agents and Tumor Biology
Published Abstract: #3143
Session: June 1, 2024 | 9 AM - 12 PM CDT
Location: Exhibit Hall

Can you spare 10 minutes at ASCO 2024?

We look forward to meeting industry peers and partners and sharing how our collaboration can unlock critical innovations we need to one day realize our vision: a world where precision therapy offers a cure for every cancer patient.

Dr. John Marshall will be among our guests at the Indivumed booth. Will you be there?

MEET US IN HALL A
BOOTH 32137

Our ASCO team is excited to meet you. Simply click the button to schedule an appointment.
 

BOOK AN APPOINTMENT

You can't attend this year?

Visit our main website to get a complete picture of Indivumed Therapeutics. Check out our videos, latest news, our publications, or get in touch with our team.